Literature DB >> 16268975

Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.

F Cadeddu1, A R Bentivoglio, F Brandara, G Marniga, G Brisinda, G Maria.   

Abstract

BACKGROUND: Constipation is one of the most common autonomic dysfunctions observed in Parkinson's disease. AIM: To investigate the efficacy of injections of botulinum toxin in improving rectal emptying in these patients.
METHODS: Eighteen Parkinson's disease patients with outlet constipation were included in the study. The patients were treated with type A botulinum toxin, injected into two sites on either side of the puborectalis muscle under ultrasonographic guidance.
RESULTS: Symptomatic improvement was noted in 10 patients, at 2 months evaluation. In these subjects, anorectal manometry demonstrated decreased tone during straining from 96.2 +/- 17.1 to 45.9 +/- 16.2 mmHg at 1 month evaluation (P = 0.00001) and to 56.1 +/- 10.7 mmHg at 2 months (P = 0.00001). Pressure during straining was lower than resting anal pressure at the same times in all patients. Defecography after the treatment showed improvement in anorectal angle during straining, which increased from 99.1 +/- 8.4 degrees to 121.7 +/- 12.7 degrees (P = 0.00001) at 2 months.
CONCLUSIONS: Botulinum toxin injections may be a useful treatment for Parkinson's disease patients affected by outlet-obstruction constipation. The treatment is safe and simple. However, because the effects of the toxin wear off within 3 months of administration, repeated injections could be necessary to maintain the clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16268975     DOI: 10.1111/j.1365-2036.2005.02669.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  22 in total

Review 1.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 3.  Functional Disorders of Constipation: Paradoxical Puborectalis Contraction and Increased Perineal Descent.

Authors:  Isaac Payne; Leander M Grimm
Journal:  Clin Colon Rectal Surg       Date:  2017-02

Review 4.  The Role of Botox in Colorectal Disorders.

Authors:  Dan Carter; Ram Dickman
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 5.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

Review 6.  An update on the use of botulinum toxin therapy in Parkinson's disease.

Authors:  Reversa Mills; Laxman Bahroo; Fernando Pagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

7.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

8.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

Review 9.  Gastrointestinal dysfunction in movement disorders.

Authors:  Ryuji Sakakibara
Journal:  Neurol Sci       Date:  2021-02-04       Impact factor: 3.307

Review 10.  Bladder and bowel dysfunction in Parkinson's disease.

Authors:  R Sakakibara; T Uchiyama; T Yamanishi; K Shirai; T Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-03-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.